Feedback / Questions
ND-081 - Numab
https://www.globenewswire.com/news-release/2024/11/15/2981815/0/en/Numab-Therapeutics-and-Kaken-Pharmaceutical-Enter-Collaboration-and-Option-Agreement-for-Multi-specific-Antibody-ND081-for-Treatment-of-Inflammatory-Bowel-Disease.html
Nov 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next